Showing results (201-210 of 459) with videos related to

Sort By:
Pageof 46
Rheumatology International|December 28, 2011
Prevalence and factors affecting glucosamine use in Korea: a survey-based studyHyun-Ju Seo, Yoon-Kyoung Sung, Chan-Bum Choi, et al.
Seminars in Arthritis and Rheumatism|December 20, 2019
An increased disease burden of autoimmune inflammatory rheumatic diseases in KoreaHyoungyoung Kim, Soo-Kyung Cho, Jin Wook Kim, et al.
Seminars in Arthritis and Rheumatism|February 21, 2017
Safety of resuming biologic DMARDs in patients who develop tuberculosis after anti-TNF treatmentSoo-Kyung Cho, Dam Kim, Soyoung Won, et al.
Journal of Korean Medical Science|October 16, 2002
Higher prevalence of peripheral arthritis among ankylosing spondylitis patientsJi-Hyun Lee, Jae-Bum Jun, Sungsoo Jung, et al.
Journal of Korean Medical Science|February 19, 2002
Undifferentiated spondyloarthropathy in Korea: focusing on peripheral arthritisTae Hwan Kim, Hye Soon Lee, Jong Dae Ji, et al.
BMC Musculoskeletal Disorders|January 9, 2013
Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritisSang-Cheol Bae, Suk Chyn Gun, Chi Chiu Mok, et al.
The Journal of Rheumatology|May 17, 2013
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: results through 2 years of the GO-FORWARD study extensionEdward C Keystone, Mark C Genovese, Stephen Hall, et al.
Journal of Korean Medical Science|October 26, 2021
Fracture Risk and Its Prevention Patterns in Korean Patients with Polymyalgia Rheumatica: a Retrospective Cohort StudyBora Nam, Yoon-Kyoung Sung, Chan-Bum Choi, et al.
The Journal of Nutritional Biochemistry|January 22, 2013
Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in KoreaYongsoon Park, AeRi Lee, Seung-Cheol Shim, et al.
RMD Open|July 3, 2021
Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South KoreaYoshiya Tanaka, Sang-Cheol Bae, Damon Bass, et al.
Pageof 46